Cumberland Pharmaceuticals (CPIX) Assets Average (2011 - 2026)

Cumberland Pharmaceuticals (CPIX) has 16 years of Assets Average data on file, last reported at $73.9 million in Q1 2026.

• For the quarter ending Q1 2026, Assets Average rose 1.58% year-over-year to $73.9 million; the trailing twelve-month figure through Mar 2026 stood at $73.9 million (up 1.58% YoY), and the FY2025 full-year result was $76.2 million, down 3.15% from the prior year.
• Assets Average grew to $73.9 million in Q1 2026, from $71.4 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $94.6 million in Q2 2022 to a low of $66.9 million in Q3 2025.
• A 5-year average of $81.9 million and a median of $81.6 million in 2024 frame the typical range for Assets Average.
• Across the five-year window, Assets Average climbed 6.78% in 2022 and slipped 13.86% in 2025, its largest moves.
• Tracing CPIX's Assets Average over 5 years: stood at $91.9 million in 2022, then retreated by 7.72% to $84.8 million in 2023, then dropped by 10.14% to $76.2 million in 2024, then retreated by 6.31% to $71.4 million in 2025, then advanced by 3.57% to $73.9 million in 2026.
• Business Quant data shows CPIX's Assets Average at $73.9 million in Q1 2026, $71.4 million in Q4 2025, and $66.9 million in Q3 2025.